Health Condition 1: J309- Allergic rhinitis, unspecified
Conditions
Interventions
Intervention1: Nasya with 3ml Shadabindu taila three times i.e. 3ml each (9ml total): Nasya with 3ml Shadabindu taila three times i.e. 3ml each (9ml total) on 7 alternate days
Control Intervention
Sponsors
NIL
Eligibility
Inclusion criteria
Inclusion criteria: a) Patients having SFAR score �7 will be labelled as patient of Allergic Rhinitis and will be included in stydy. b) Patients who are fit for Nasya karma i.e. Nasyarha. c) Patients in the age group of 18-70 years. d) Patients willing to discontinue their previous medicines regarding allergic rhinitis will be given the gap of 2 week.
Exclusion criteria
Exclusion criteria: a) Patients who fit in the criteria of Nasya anarha21. b) Patients who are not willing for nasya. c) Patients having conditions like Nasal polyps, Carcinomas of nose, Rhinitis with recurrent epistaxis, Acute infective rhinitis, Atrophic rhinitis, Hypertrophic rhinitis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Validation of Nasya efficacy in the management of Allergic rhinitis.Timepoint: 2 weeks and 4 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Clarification regarding dosing pattern of Charakokta Nasya methodology. Timepoint: 2 weeks and 4 weeks ;Standardization of Charakokta Nasya methodology. Timepoint: 2 weeks and 4 weeks | — |
Countries
India
Contacts
Public ContactDr Mamta Mahadevrao Nakade
Shri Ayurved Mahavidyalaya, Nagpur
Outcome results
None listed